and therein lies the LymPro challenge
1.) outright BP sale
2.) inlicensure
3.) spin off
4.) JV partnership
Gerald has not clarified which direction
may options, but no clear cut path - yet............
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
-
-
-
-
-
-
-